Latest stories

  • in

    CCI approves acquisition of up to 76.10 percent of voting share capital of Suven Pharma by Berhyanda

    New Delhi: Anti-trust regulator Competition Commission of India (CCI) approves the acquisition of up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited by Berhyanda Limited. The proposed combination relates to acquisition by Berhyanda Limited (Acquirer) for up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited (Target), by way of a […] More

  • in

    Dr Reddys Labs concludes acquisition of Mayne Pharma’s US generic prescription product portfolio

    Dr Reddys Labs concludes acquisition of Mayne Pharma's US generic prescription product portfolio

    Hyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma’s U.S. generic prescription product portfolio. The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health. For the financial period ended June […] More